Modulation involving back combination with BMP-2, MEK inhibitor (Bleomycin), along with zoledronic acid solution inside a murine model of NF1 dual inactivation | #Lenvatinib #Bleomycin #PIK-5
Modulation involving back combination with BMP-2, MEK inhibitor (Bleomycin), along with zoledronic acid solution inside a murine model of NF1 dual inactivation | #Lenvatinib #Bleomycin #PIK-5